Provided by Tiger Trade Technology Pte. Ltd.

Vivos Therapeutics

0.1459
-0.0020-1.35%
Volume:417.17K
Turnover:60.32K
Market Cap:2.94M
PE:-0.08
High:0.1475
Open:0.1440
Low:0.1431
Close:0.1479
52wk High:3.42
52wk Low:0.1289
Shares:20.12M
Float Shares:19.98M
Volume Ratio:0.17
T/O Rate:2.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8267
EPS(LYR):-2.0700
ROE:-8585.26%
ROA:-56.19%
PB:-0.60
PE(LYR):-0.07

Loading ...

Vivos Therapeutics Q2 Revenue Rises 35% on Service Growth

Reuters
·
Aug 15

Vivos Therapeutics Q2 Net Income USD -5.523 Million

Reuters
·
Aug 15

Vivos Therapeutics Q2 Gross Profit USD 2.953 Million

THOMSON REUTERS
·
Aug 15

Vivos Therapeutics Q2 EPS $(0.31) Beats $(0.36) Estimate, Sales $5.153M Miss $5.367M Estimate

Benzinga Earnings
·
Aug 15

Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call

GlobeNewswire
·
Aug 14

Vivos Therapeutics Inc Expected to Post a Loss of 39 Cents a Share - Earnings Preview

Reuters
·
Aug 14

Vivos Therapeutics Strengthens IP for Sleep Apnea Devices

TIPRANKS
·
Aug 12

Vivos Therapeutics Kantongi Paten as Baru Untuk Teknologi Perangkat Oral Vivos CARE

Reuters
·
Aug 12

Vivos Therapeutics Expands Greenway Health Partnership to Roll Out Novare AI Platform Across Operations

Reuters
·
Aug 11

Vivos Therapeutics Expands Greenway Health Partnership to Deploy AI-Enabled Platform Across All Clinical and Revenue Operations

THOMSON REUTERS
·
Aug 11

Vivos Therapeutics issued new U.S. patent for Vivos CARE devices

TIPRANKS
·
Aug 05

Vivos Therapeutics Wins New US Patent Covering Vivos CARE Oral Device Technology

Reuters
·
Aug 05

Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos Care Oral Medical Device Technology

THOMSON REUTERS
·
Aug 05

Top Premarket Decliners

MT Newswires Live
·
Aug 05

Vivos Therapeutics Appoints New Chief Financial Officer

TIPRANKS
·
Aug 04

Vivos Therapeutics - Appoints Roman Franklin as Chief Financial Officer Effective July 31, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 04

Vivos Therapeutics Names Roman Franklin CFO as Bradford Amman Resigns

Reuters
·
Aug 04

Vivos Therapeutics Discloses V-co Investors 4 as Beneficial Owner in Form 3 Filing

Reuters
·
Jul 16

Vivos Therapeutics price target lowered to 75c from $1.75 at Alliance Global

TIPRANKS
·
Jul 09

Vivos Therapeutics Creates New Series A Preferred Stock

TIPRANKS
·
Jul 08